Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report

P Malfertheiner, F Megraud, CA O'Morain, J Atherton… - Gut, 2012 - gut.bmj.com
Management of Helicobacter pylori infection is evolving and in this 4th edition of the
Maastricht consensus report aspects related to the clinical role of H pylori were looked at …

Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised …

AC Ford, D Forman, RH Hunt, Y Yuan, P Moayyedi - Bmj, 2014 - bmj.com
Objectives To determine whether searching for Helicobacter pylori and treating with
eradication therapy leads to a reduction in incidence of gastric cancer among healthy …

[HTML][HTML] Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer

YH Park, N Kim - Journal of cancer prevention, 2015 - ncbi.nlm.nih.gov
Atrophic gastritis (AG) and intestinal metaplasia (IM) are the main precursor lesions of
gastric cancer as the incidence of gastric cancer increases in the gastric mucosa involved …

Helicobacter pylori eradication for the prevention of gastric neoplasia

AC Ford, Y Yuan, D Forman, R Hunt… - … of systematic reviews, 2020 - cochranelibrary.com
Background Gastric cancer is the third most common cause of cancer death worldwide.
Individuals infected with Helicobacter pylori have a higher likelihood of developing gastric …

Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition

M Asaka, M Kato, S Takahashi, Y Fukuda… - …, 2010 - Wiley Online Library
Background: Over the past few years, the profile of Helicobacter pylori infection has changed
in Japan. In particular, the relationship between H. pylori and gastric cancer has been …

[HTML][HTML] Safety of the long-term use of proton pump inhibitors

ABR Thomson, MD Sauve, N Kassam… - World journal of …, 2010 - ncbi.nlm.nih.gov
The proton pump inhibitors (PPIs) as a class are remarkably safe and effective for persons
with peptic ulcer disorders. Serious adverse events are extremely rare for PPIs, with case …

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions

W You, LM Brown, L Zhang, J Li, M Jin… - Journal of the …, 2006 - academic.oup.com
Background: Randomized trials have yielded mixed results on the effects of treatment for
Helicobacter pylori and little information on the effects of vitamins or garlic supplements on …

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication

WK Leung, SR Lin, JYL Ching, KF To, EKW Ng… - Gut, 2004 - gut.bmj.com
Background and aim: Gastric intestinal metaplasia (IM) is generally considered to be a
precancerous lesion in the gastric carcinogenesis cascade. This study identified the risk …

Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive …

E Lahner, RM Zagari, A Zullo, A Di Sabatino… - Digestive and liver …, 2019 - Elsevier
Chronic atrophic gastritis (CAG) is an underdiagnosed condition characterised by
translational features going beyond the strict field of gastroenterology as it may manifest …

[HTML][HTML] Helicobacter pylori and gastric adenocarcinoma

V Herrera, J Parsonnet - Clinical Microbiology and Infection, 2009 - Elsevier
Gastric cancer is the second most common cause of cancer death worldwide. A large body
of evidence supports a causal role of Helicobacter pylori in the majority of gastric …